SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-249866
Filing Date
2017-08-07
Accepted
2017-08-07 16:07:13
Documents
76
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d412831d10q.htm 10-Q 717371
2 EX-10.3 d412831dex103.htm EX-10.3 380244
3 EX-31.1 d412831dex311.htm EX-31.1 6288
4 EX-31.2 d412831dex312.htm EX-31.2 6280
5 EX-32.1 d412831dex321.htm EX-32.1 4422
6 EX-32.2 d412831dex322.htm EX-32.2 4413
13 GRAPHIC g412831page054.jpg GRAPHIC 235814
  Complete submission text file 0001193125-17-249866.txt   5982938

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnkd-20170630.xml EX-101.INS 832591
8 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20170630.xsd EX-101.SCH 65282
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20170630_cal.xml EX-101.CAL 80284
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20170630_def.xml EX-101.DEF 401297
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20170630_lab.xml EX-101.LAB 517209
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20170630_pre.xml EX-101.PRE 462971
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 171011550
SIC: 2834 Pharmaceutical Preparations